Firebrick Pharma Limited (FRE.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.01 AUD | 83.5% |
| 2023 | -0.04 AUD | -77.78% |
| 2022 | -0.02 AUD | -56.25% |
| 2021 | -0.01 AUD | -61.8% |
| 2020 | -0.01 AUD | -106.98% |
| 2019 | -0.00 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 FY | - AUD | 83.5% |
| 2024 Q4 | -0.00 AUD | 12.5% |
| 2024 Q1 | -0.00 AUD | 88.32% |
| 2024 Q2 | -0.01 AUD | -104.0% |
| 2024 Q3 | -0.00 AUD | 84.31% |
| 2023 Q1 | -0.01 AUD | 30.6% |
| 2023 FY | - AUD | -77.78% |
| 2023 Q4 | -0.02 AUD | -100.0% |
| 2023 Q3 | -0.01 AUD | 42.16% |
| 2023 Q2 | -0.02 AUD | -98.92% |
| 2022 Q4 | -0.01 AUD | -35.35% |
| 2022 FY | - AUD | -56.25% |
| 2022 Q3 | -0.01 AUD | -8.79% |
| 2022 Q2 | -0.01 AUD | -42.19% |
| 2022 Q1 | -0.01 AUD | 25.58% |
| 2021 Q1 | -0.00 AUD | 0.0% |
| 2021 FY | - AUD | -61.8% |
| 2021 Q4 | -0.01 AUD | -30.3% |
| 2021 Q3 | -0.01 AUD | -13.79% |
| 2021 Q2 | -0.01 AUD | -31.82% |
| 2020 FY | - AUD | -106.98% |
| 2019 FY | - AUD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Mayne Pharma Group Limited | -2.19 AUD | 99.699% |